Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6554)
All Articles published online
|
Feb 21, 2012 (publication date) through Dec 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He W, Li K, Wang F, Qin YR, Fan QX. Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. World J Gastroenterol 2012; 18(7): 712-719 [PMID: 22363145 DOI: 10.3748/wjg.v18.i7.712] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i7/712.htm |
| Number | Citing Articles |
| 1 |
XINZHENG DAI, JING GE, XUEHAO WANG, XIAOFENG QIAN, CHUANYONG ZHANG, XIANGCHENG LI. OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion. Oncology Reports 2013; 29(1): 155 doi: 10.3892/or.2012.2086
|
| 2 |
Feng Wang, Xiao-Yan Xuan, Xuan Yang, Lei Cao, Li-Na Pang, Ran Zhou, Qin-Xia Fan, Liu-Xing Wang. Stathmin is a Marker of Progression and Poor Prognosis in Esophageal Carcinoma. Asian Pacific Journal of Cancer Prevention 2014; 15(8): 3613 doi: 10.7314/APJCP.2014.15.8.3613
|
| 3 |
Chantel Samardzija, Michael Quinn, Jock K Findlay, Nuzhat Ahmed. Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary. Journal of Ovarian Research 2012; 5(1) doi: 10.1186/1757-2215-5-37
|
| 4 |
Beilong Zhong, Yan Lin, Yingrong Lai, Fangfang Zheng, Xiaobin Zheng, Rijiao Huang, Weilin Yang, Zhenguang Chen. Relationship of Oct-4 to malignant stage: a meta-analysis based on 502 positive/high Oct-4 cases and 522 negative/low case-free controls. Oncotarget 2016; 7(2): 2143 doi: 10.18632/oncotarget.5737
|
| 5 |
Samir Kumar Patra. Roles of OCT4 in pathways of embryonic development and cancer progression. Mechanisms of Ageing and Development 2020; 189: 111286 doi: 10.1016/j.mad.2020.111286
|
| 6 |
Ismail S. Mohiuddin, Sung-Jen Wei, Min H. Kang. Role of OCT4 in cancer stem-like cells and chemotherapy resistance. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(4): 165432 doi: 10.1016/j.bbadis.2019.03.005
|
| 7 |
Kun‐Jing Hong, Deng‐Chyang Wu, Kuang‐Hung Cheng, Li‐Tzong Chen, Wen‐Chun Hung. RECK Inhibits Stemness Gene Expression and Tumorigenicity of Gastric Cancer Cells by Suppressing ADAM‐Mediated Notch1 Activation. Journal of Cellular Physiology 2014; 229(2): 191 doi: 10.1002/jcp.24434
|
| 8 |
Dingdong He, Xiaokang Zhang, Jiancheng Tu. Diagnostic significance and carcinogenic mechanism of pan‐cancer gene POU5F1 in liver hepatocellular carcinoma. Cancer Medicine 2020; 9(23): 8782 doi: 10.1002/cam4.3486
|
| 9 |
RUMI YOSHIHAMA, KOUJIRO YAMAGUCHI, IKUMI IMAJYO, MARIKO MINE, NAOMI HIYAKE, NAONARI AKIMOTO, YOSUKE KOBAYASHI, SATOMI CHIGITA, WATARU KUMAMARU, TAMOTSU KIYOSHIMA, YOSHIHIDE MORI, TSUYOSHI SUGIURA. Expression levels of SOX2, KLF4 and brachyury transcription factors are associated with metastasis and poor prognosis in oral squamous cell carcinoma. Oncology Letters 2016; 11(2): 1435 doi: 10.3892/ol.2015.4047
|
| 10 |
Olga A Cherepanova, Delphine Gomez, Laura S Shankman, Pamela Swiatlowska, Jason Williams, Olga F Sarmento, Gabriel F Alencar, Daniel L Hess, Melissa H Bevard, Elizabeth S Greene, Meera Murgai, Stephen D Turner, Yong-Jian Geng, Stefan Bekiranov, Jessica J Connelly, Alexey Tomilin, Gary K Owens. Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective. Nature Medicine 2016; 22(6): 657 doi: 10.1038/nm.4109
|
| 11 |
Anda Huna, Kristine Salmina, Jekaterina Erenpreisa, Alejandro Vazquez-Martin, Jekabs Krigerts, Inna Inashkina, Bogdan I Gerashchenko, Paul A Townsend, Mark S Cragg, Thomas R Jackson. Role of stress-activated OCT4A in the cell fate decisions of embryonal carcinoma cells treated with etoposide. Cell Cycle 2015; 14(18): 2969 doi: 10.1080/15384101.2015.1056948
|
| 12 |
Xiaoyan Zhao, Hui Lu, Yan Sun, Li Liu, Huafang Wang. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors. Medicine 2020; 99(42): e22804 doi: 10.1097/MD.0000000000022804
|
| 13 |
Songpol Srinual, Pithi Chanvorachote, Varisa Pongrakhananon. Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway. International Journal of Oncology 2017; 50(4): 1341 doi: 10.3892/ijo.2017.3879
|
| 14 |
Si Kei, Oyedele A. Adeyi. Practical Application of Lineage-Specific Immunohistochemistry Markers: Transcription Factors (Sometimes) Behaving Badly. Archives of Pathology & Laboratory Medicine 2020; 144(5): 626 doi: 10.5858/arpa.2019-0226-RA
|
| 15 |
HAI LIN, LI-HUA SUN, WEI HAN, TIE-YING HE, XIN-JIAN XU, KUN CHENG, CHENG GENG, LI-DAN SU, HAO WEN, XI-YAN WANG, QI-LONG CHEN. Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway. Molecular Medicine Reports 2014; 10(3): 1335 doi: 10.3892/mmr.2014.2367
|
| 16 |
Bo Wook Kim, Hanbyoul Cho, Chel Hun Choi, Kris Ylaya, Joon-Yong Chung, Jae-Hoon Kim, Stephen M. Hewitt. Clinical significance of OCT4 and SOX2 protein expression in cervical cancer. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-2015-1
|
| 17 |
Xiao-zheng Zou, Xiu-hua Zhou, Ying-qi Feng, Jun-feng Hao, Bing Liang, Meng-wei Jia. Novel inhibitor of OCT1 enhances the sensitivity of human esophageal squamous cell carcinoma cells to antitumor agents. European Journal of Pharmacology 2021; 907: 174222 doi: 10.1016/j.ejphar.2021.174222
|
| 18 |
Pinelopi Bosgana, Sophia Nikou, Foteinos-Ioannis Dimitrakopoulos, Vasiliki Bravou, Charalambos Kalophonos, Eleni Kourea, Vasiliki Tzelepi, Vassiliki Zolota, Fotios Sampsonas. Expression of Pluripotency Factors OCT4 and LIN28 Correlates with Survival Outcome in Lung Adenocarcinoma. Medicina 2024; 60(6): 870 doi: 10.3390/medicina60060870
|
| 19 |
HUAN ZHOU, YU HU, WEIPENG WANG, YONG MAO, JINGJIE ZHU, BIN ZHOU, JING SUN, XUEGUANG ZHANG. Expression of Oct-4 is significantly associated with the development and prognosis of colorectal cancer. Oncology Letters 2015; 10(2): 691 doi: 10.3892/ol.2015.3269
|
| 20 |
Wojciech Jóźwicki, Anna Brożyna, Jerzy Siekiera. Expression of OCT4A: The First Step to the Next Stage of Urothelial Bladder Cancer Progression. International Journal of Molecular Sciences 2014; 15(9): 16069 doi: 10.3390/ijms150916069
|
| 21 |
Homa Mollaei, Mohammad Reza Abedini, Reyhane Hoshyar. Suppressive Effect of Crocin and Cisplatin on Pluripotency Genes Expression in Human Cervical Cancer Cells. International Journal of Cancer Management 2017; 10(10) doi: 10.5812/ijcm.11152
|
| 22 |
Nevine M.F. El Deeb, Eman Abdelzaher. Stem cell markers OCT4 and nestin in laryngeal squamous cell carcinoma and their relation to survivin expression. Pathology - Research and Practice 2014; 210(11): 751 doi: 10.1016/j.prp.2014.06.005
|
| 23 |
Kim Vaiphei, Saroj Kant Sinha, Rakesh Kochhar. Comparative Analysis of Oct4 in Different Histological Subtypes of Esophageal Squamous Cell Carcinomas in Different Clinical Conditions. Asian Pacific Journal of Cancer Prevention 2014; 15(8): 3519 doi: 10.7314/APJCP.2014.15.8.3519
|
| 24 |
Vinayak Nagaraja, Guy D Eslick. Advances in biomarkers for esophageal cancer. Expert Review of Anticancer Therapy 2013; 13(10): 1169 doi: 10.1586/14737140.2013.844953
|
| 25 |
Mousa A. Shaheen, Nedal A. Hegazy, Ola H. Nada, Nehal A. Radwan, Suzan M. Talaat. Immunohistochemical expression of stem cell markers CD133 and Oct4 in colorectal adenocarcinoma. Egyptian Journal of Pathology 2014; 34(1): 44 doi: 10.1097/01.XEJ.0000446922.00388.27
|
| 26 |
Doreya M. Bayoumi, Dina M. Abdallah, Menatallah M. Hosney. The role of immunohistochemical expression of OCT-4 and SOX2 as predictors of recurrence and progression in superficial urinary bladder carcinoma. Egyptian Journal of Pathology 2017; 37(1): 17 doi: 10.1097/01.XEJ.0000515976.40228.b9
|
| 27 |
Emilly Schlee Villodre, Franciele Cristina Kipper, Mariana Brutschin Pereira, Guido Lenz. Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis. Cancer Treatment Reviews 2016; 51: 1 doi: 10.1016/j.ctrv.2016.10.003
|
| 28 |
ZHONG-SHU CHEN, DONG-JIN LING, YANG-DE ZHANG, JIAN-XIONG FENG, XUE-YU ZHANG, TIAN-SHENG SHI. Octamer-binding protein 4 affects the cell biology and phenotypic transition of lung cancer cells involving β-catenin/E-cadherin complex degradation. Molecular Medicine Reports 2015; 11(3): 1851 doi: 10.3892/mmr.2014.2992
|
| 29 |
Tieju Liu, Baocun Sun, Xiulan Zhao, Yanlei Li, Qiang Gu, Xueyi Dong, Fang Liu. OCT4 Expression and Vasculogenic Mimicry Formation Positively Correlate with Poor Prognosis in Human Breast Cancer. International Journal of Molecular Sciences 2014; 15(11): 19634 doi: 10.3390/ijms151119634
|
| 30 |
Zhiqiang Chen, Long Zhang, Qin Zhu, Xiaowei Wang, Jindao Wu, Xuehao Wang. Clinical value of octamer‐binding transcription factor 4 as a prognostic marker in patients with digestive system cancers: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2017; 32(3): 567 doi: 10.1111/jgh.13624
|
| 31 |
Doria Filipponi, Marina Pagnuzzi-Boncompagni, Gilles Pagès. Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma. Cancers 2022; 14(9): 2095 doi: 10.3390/cancers14092095
|
| 32 |
Justine Lai, Chuquan Shang, Will Chen, Iyare Izevbaye, Michael P. Chu, Irwindeep Sandhu, Joseph Brandwein, Raymond Lai, Peng Wang. An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter. International Journal of Molecular Sciences 2023; 25(1): 496 doi: 10.3390/ijms25010496
|